Community feedback highlights the importance of CF care teams, in-person CF care, and telehealth.
Site Search
Showing 441 - 442 of 442 results
News
|
May 7, 2024
|
4 min read
With this approval, approximately 2,250 children in the U.S. will be eligible for Trikafta® (elexacaftor/tezacaftor/ivacaftor), including more than 900 who will have access to a CFTR modulator for the first time. The Cystic Fibrosis Foundation believes it is beneficial to start people with cystic fibrosis on modulators as early as possible to help prevent lung damage and the onset of complications.
News
|
April 26, 2023
|
3 min read